4//SEC Filing
Moore Matthew Richard 4
Accession 0001787306-24-000004
CIK 0001787306other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:28 PM ET
Size
7.6 KB
Accession
0001787306-24-000004
Insider Transaction Report
Form 4
Moore Matthew Richard
SVP and Chief Business Officer
Transactions
- Award
Common Stock
2024-01-12+28,000→ 54,590 total - Award
Stock Option (Right to Buy)
2024-01-12+126,000→ 126,000 totalExercise: $3.64Exp: 0034-01-12→ Common Stock (126,000 underlying)
Footnotes (2)
- [F1]Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on February 1, (the "Vesting Commencement Date"), of each year, beginning on February 1, 2025, subject to the Reporting Person's continued service to the issuer.
- [F2]1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001840191
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:28 PM ET
- Size
- 7.6 KB